Published in Int Ophthalmol on August 22, 2015
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol (1985) 17.20
Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol (2003) 6.31
Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology (2002) 5.99
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91
Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology (2004) 2.38
Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema. Retina (2015) 2.08
Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther (2010) 1.30
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg (2009) 1.23
Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Retina (2010) 1.09
Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. Graefes Arch Clin Exp Ophthalmol (2010) 1.00
The course of response to focal/grid photocoagulation for diabetic macular edema. Retina (2009) 0.99
Improvement of visual acuity based on optical coherence tomography patterns following intravitreal bevacizumab treatment in patients with diabetic macular edema. Int J Ophthalmol (2014) 0.85
Treatment of diffuse diabetic macular oedema using steroid eye drops. Acta Ophthalmol (2011) 0.82